Linked Life Data

17334266

Source:http://linkedlifedata.com/resource/pubmed/id/17334266

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17334266rdf:typepubmed:Citationlld:pubmed
pubmed-article:17334266lifeskim:mentionsumls-concept:C0241888lld:lifeskim
pubmed-article:17334266lifeskim:mentionsumls-concept:C1838318lld:lifeskim
pubmed-article:17334266lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:17334266lifeskim:mentionsumls-concept:C0751072lld:lifeskim
pubmed-article:17334266lifeskim:mentionsumls-concept:C1415311lld:lifeskim
pubmed-article:17334266lifeskim:mentionsumls-concept:C0019409lld:lifeskim
pubmed-article:17334266pubmed:issue1lld:pubmed
pubmed-article:17334266pubmed:dateCreated2007-3-5lld:pubmed
pubmed-article:17334266pubmed:abstractTextHereditary dysphasic disinhibition dementia (HDDD) describes a familial disorder characterized by personality changes, and language and memory deficits. The neuropathology includes frontotemporal lobar atrophy, neuronal loss and gliosis and, in most cases, abundant Abeta plaques and neurofibrillary tangles (NFTs). A Pick/Alzheimer's spectrum was proposed for the original family (HDDD1). Here we report the clinicopathologic case of an HDDD1 individual using modern immunohistochemical methods, contemporary neuropathologic diagnostic criteria to distinguish different frontotemporal lobar degenerations (FTLDs), and progranulin (PRGN) mutation analysis. Clinical onset was at age 62 years with personality changes and disinhibition, followed by nonfluent dysphasia, and memory loss that progressed to muteness and total dependence with death at age 84 years. There was severe generalized brain atrophy (weight=570 g). Histopathology showed superficial microvacuolation, marked neuronal loss, gliosis, and ubiquitin-positive, tau-negative cytoplasmic and intranuclear neuronal inclusions in frontal, temporal, and parietal cortices. There were also frequent neuritic plaques and NFTs in parietal and occipital cortices. The case met neuropathologic criteria for both FTLD with ubiquitin-positive, tau-negative inclusions (FTLD-U), and Alzheimer disease (Braak NFT stage V). We discovered a novel pathogenic PGRN mutation c.5913 A>G (IVS6-2 A>G) segregating with FTLD-U in this kindred. In conclusion, HDDD1 is an FTLD-U caused by a PGRN mutation and is neuropathologically heterogeneous with Alzheimer disease as a common comorbidity.lld:pubmed
pubmed-article:17334266pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17334266pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17334266pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17334266pubmed:languageenglld:pubmed
pubmed-article:17334266pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17334266pubmed:citationSubsetIMlld:pubmed
pubmed-article:17334266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17334266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17334266pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17334266pubmed:statusMEDLINElld:pubmed
pubmed-article:17334266pubmed:issn0893-0341lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:MorrisJohn...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:CairnsNigel...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:ChakravertySu...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:GoateAlison...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:TuPang-hsienP...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:BehrensMaria...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:MukherjeeOdit...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:Taylor-Reinwa...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:GitchoMichael...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:LiscicRajka...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:GrinbergLea...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:CarterDeborah...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:PaulsmeyerKat...lld:pubmed
pubmed-article:17334266pubmed:authorpubmed-author:NortonJoanne...lld:pubmed
pubmed-article:17334266pubmed:issnTypePrintlld:pubmed
pubmed-article:17334266pubmed:volume21lld:pubmed
pubmed-article:17334266pubmed:ownerNLMlld:pubmed
pubmed-article:17334266pubmed:authorsCompleteYlld:pubmed
pubmed-article:17334266pubmed:pagination1-7lld:pubmed
pubmed-article:17334266pubmed:dateRevised2007-12-3lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:meshHeadingpubmed-meshheading:17334266...lld:pubmed
pubmed-article:17334266pubmed:articleTitleNeuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation.lld:pubmed
pubmed-article:17334266pubmed:affiliationAlzheimer's Disease Research Center, Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA.lld:pubmed
pubmed-article:17334266pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17334266pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:17334266pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17334266pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17334266lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17334266lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17334266lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17334266lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17334266lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17334266lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17334266lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17334266lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17334266lld:pubmed